{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:51:20Z","timestamp":1793213480620,"version":"4.5.0"},"reference-count":133,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T00:00:00Z","timestamp":1619308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Poor vitamin D status is common in patients with impaired renal function and represents one main component of the complex scenario of chronic kidney disease\u2013mineral and bone disorder (CKD\u2013MBD). Therapeutic and dietary efforts to limit the consequences of uremia-associated vitamin D deficiency are a current hot topic for researchers and clinicians in the nephrology area. Evidence indicates that the low levels of vitamin D in patients with CKD stage above 4 (GFR &lt; 15 mL\/min) have a multifactorial origin, mainly related to uremic malnutrition, namely impaired gastrointestinal absorption, dietary restrictions (low-protein and low-phosphate diets), and proteinuria. This condition is further worsened by the compromised response of CKD patients to high-dose cholecalciferol supplementation due to the defective activation of renal hydroxylation of vitamin D. Currently, the literature lacks large and interventional studies on the so-called non-calcemic activities of vitamin D and, above all, the modulation of renal and cardiovascular functions and immune response. Here, we review the current state of the art of the benefits of supplementation with native vitamin D in various clinical settings of nephrological interest: CKD, dialysis, and renal transplant, with a special focus on the effects on bone homeostasis and cardiovascular outcomes.<\/jats:p>","DOI":"10.3390\/nu13051453","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T02:12:57Z","timestamp":1619316777000},"page":"1453","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Vitamin D Effects on Bone Homeostasis and Cardiovascular System in Patients with Chronic Kidney Disease and Renal Transplant Recipients"],"prefix":"10.3390","volume":"13","author":[{"given":"Giuseppe","family":"Cianciolo","sequence":"first","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2592-9532","authenticated-orcid":false,"given":"Maria","family":"Cappuccilli","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tondolo","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gasperoni","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia","family":"Zappulo","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Barbuto","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Iacovella","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Conte","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Capelli","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"La Manna","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"105489","DOI":"10.1016\/j.jsbmb.2019.105489","article-title":"Vitamin D microencapsulation and fortification: Trends and technologies","volume":"196","author":"Maurya","year":"2020","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_2","unstructured":"Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., de Herder, W.W., Dungan, K., Grossman, A., Hershman, J.M., Hofland, J., and Kaltsas, G. (2000). Vitamin D: Production, Metabolism, and Mechanisms of Action. Endotext, MDText.com, Inc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fendo.2019.00910","article-title":"Vitamin D Binding Protein: A Historic Overview","volume":"10","author":"Bouillon","year":"2019","journal-title":"Front Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Cirillo, M., Bilancio, G., Guarino, E., Cavallo, P., Lombardi, C., Costanzo, S., De Curtis, A., Di Castelnuovo, A., and Iacoviello, L. (2019). Vitamin D Status and Indices of Mineral Homeostasis in the Population: Differences Between 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D. Nutrients, 11.","DOI":"10.3390\/nu11081777"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1093\/ndt\/gfn338","article-title":"Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol","volume":"23","author":"Valdivielso","year":"2008","journal-title":"Nephrol. Dial Transpl."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4158\/EP10325.RA","article-title":"Vitamin D receptors and parathyroid glands","volume":"17","author":"Landry","year":"2011","journal-title":"Endocr. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.abb.2012.02.016","article-title":"Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase","volume":"523","author":"Adams","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1096\/fj.06-6374fje","article-title":"Evidence for auto\/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells","volume":"20","author":"Koedam","year":"2006","journal-title":"FASEB J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/en.2010-0334","article-title":"Osteoclastic metabolism of 25(OH)-vitamin D3: A potential mechanism for optimization of bone resorption","volume":"151","author":"Kogawa","year":"2010","journal-title":"Endocrinology"},{"key":"ref_12","first-page":"129","article-title":"Autocrine and paracrine actions of vitamin d","volume":"31","author":"Morris","year":"2010","journal-title":"Clin. Biochem. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Jean, G., Souberbielle, J.C., and Chazot, C. (2017). Vitamin D in Chronic Kidney Disease and Dialysis Patients. Nutrients, 9.","DOI":"10.3390\/nu9040328"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000325459","article-title":"VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy","volume":"32","author":"Cianciolo","year":"2011","journal-title":"Blood Purif."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1172\/JCI88887","article-title":"The vitamin D receptor: Contemporary genomic approaches reveal new basic and translational insights","volume":"127","author":"Pike","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1152\/physiol.00061.2014","article-title":"Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement","volume":"31","author":"Siddiqui","year":"2016","journal-title":"Physiology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kim, J.M., Lin, C., Stavre, Z., Greenblatt, M.B., and Shim, J.H. (2020). Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells, 9.","DOI":"10.3390\/cells9092073"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.beem.2011.05.008","article-title":"Calcemic actions of vitamin D: Effects on the intestine, kidney and bone","volume":"25","author":"Lieben","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects","volume":"96","author":"Christakos","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00223-012-9683-5","article-title":"1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: Evidence for primary and secondary mechanisms modulated by leptin and interleukin-6","volume":"92","author":"Saini","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","article-title":"Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease","volume":"90","author":"Panizo","year":"2016","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.bone.2019.07.026","article-title":"Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone","volume":"127","author":"Pereira","year":"2019","journal-title":"Bone"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1210\/me.2006-0102","article-title":"1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription","volume":"20","author":"Fretz","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1681\/ASN.2016010066","article-title":"Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D","volume":"28","author":"Karaplis","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","article-title":"Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium","volume":"110","author":"Ryan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Franca Gois, P.H., Wolley, M., Ranganathan, D., and Seguro, A.C. (2018). Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies. Int. J. Environ. Res. Public Health, 15.","DOI":"10.20944\/preprints201807.0320.v1"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/s41598-019-38522-w","article-title":"The impact of sunlight exposure on mortality of patients with end stage renal disease","volume":"9","author":"Yoon","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"116755","DOI":"10.1016\/j.lfs.2019.116755","article-title":"Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell","volume":"234","author":"Liu","year":"2019","journal-title":"Life Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ecl.2010.02.002","article-title":"Vitamin D: Metabolism","volume":"39","author":"Christakos","year":"2010","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ckj\/sfv145","article-title":"Calcifying circulating cells: An uncharted area in the setting of vascular calcification in CKD patients","volume":"9","author":"Cianciolo","year":"2016","journal-title":"Clin. Kidney J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jbmr.5650070804","article-title":"Evidence for the formation of a complex between osteopontin and osteocalcin","volume":"7","author":"Ritter","year":"1992","journal-title":"J. Bone Miner Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Fusaro, M., Cianciolo, G., Brandi, M.L., Ferrari, S., Nickolas, T.L., Tripepi, G., Plebani, M., Zaninotto, M., Iervasi, G., and La Manna, G. (2020). Vitamin K and Osteoporosis. Nutrients, 12.","DOI":"10.3390\/nu12123625"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/jbmr.1677","article-title":"Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study","volume":"27","author":"Fusaro","year":"2012","journal-title":"J. Bone Miner Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Van Ballegooijen, A.J., Beulens, J.W.J., Schurgers, L.J., de Koning, E.J., Lips, P., van Schoor, N.M., and Vervloet, M.G. (2019). Effect of 6-Month Vitamin D Supplementation on Plasma Matrix Gla Protein in Older Adults. Nutrients, 11.","DOI":"10.3390\/nu11020231"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fusaro, M., Cianciolo, G., Evenepoel, P., Schurgers, L., and Plebani, M. (2021). Vitamin K in CKD Bone Disorders. Calcif. Tissue Int.","DOI":"10.1007\/s00223-020-00792-2"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.steroids.2012.07.013","article-title":"Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum","volume":"77","author":"Janssen","year":"2012","journal-title":"Steroids"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/jcla.21955","article-title":"Analysis of 25-Hydroxyvitamin D Status According to Age, Gender, and Seasonal Variation","volume":"30","author":"Yu","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1440-1797.2006.00754.x","article-title":"Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5","volume":"12","author":"Elder","year":"2007","journal-title":"Nephrology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00467-020-04499-2","article-title":"Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: Effect of age, gender, and race","volume":"35","author":"Soeiro","year":"2020","journal-title":"Pediatric Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000446449","article-title":"Furosemide Increases the Risk of Hyperparathyroidism in Chronic Kidney Disease","volume":"43","author":"Vasco","year":"2016","journal-title":"Am. J. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bone.2016.05.012","article-title":"Seasonal changes in serum calcium, PTH and vitamin D levels in patients with primary hyperparathyroidism","volume":"89","author":"Kogan","year":"2016","journal-title":"Bone"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ckj\/sfx116","article-title":"CKD-MBD KDIGO guidelines: How difficult is reaching the \u2018target\u2019?","volume":"11","author":"Cozzolino","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: What\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40620-016-0305-6","article-title":"Vitamin D in patients with chronic kidney disease: A position statement of the Working Group \"Trace Elements and Mineral Metabolism\" of the Italian Society of Nephrology","volume":"29","author":"Morrone","year":"2016","journal-title":"J. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1053\/j.ajkd.2018.06.031","article-title":"The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation","volume":"72","author":"Melamed","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"6","author":"Kandula","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5414\/CNP73276","article-title":"Treatment of vitamin D deficiency in CKD patients with ergocalciferol: Are current K\/DOQI treatment guidelines adequate?","volume":"73","author":"Qunibi","year":"2010","journal-title":"Clin. Nephrol."},{"key":"ref_49","first-page":"643","article-title":"Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency\/Insufficiency: A Randomized Controlled Trial","volume":"98","author":"Thimachai","year":"2015","journal-title":"J. Med. Assoc. Thai"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3945\/ajcn.112.040642","article-title":"High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: A pilot, randomized, double-blind, placebo-controlled trial","volume":"96","author":"Alvarez","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Holden, R.M., Mustafa, R.A., Alexander, R.T., Battistella, M., Bevilacqua, M.U., Knoll, G., Mac-Way, F., Reslerova, M., Wald, R., and Acott, P.D. (2020). Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder. Can J. Kidney Health Dis., 7.","DOI":"10.1177\/2054358120944271"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ndt\/gfx059","article-title":"High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4: Results of a 12-week double-blind, randomized, controlled study","volume":"33","author":"Westerberg","year":"2018","journal-title":"Nephrol. Dial Transpl."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000499187","article-title":"Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease","volume":"49","author":"Strugnell","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Bover, J., Gunnarson, J., Csomor, P., Kaiser, E., Cianciolo, G., and Lauppe, R. (2021). Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: A Meta-analysis. Clin. Kidney J.","DOI":"10.1093\/ckj\/sfab035"},{"key":"ref_56","first-page":"63","article-title":"Direct suppression of Pth gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptor","volume":"46","author":"Ritter","year":"2011","journal-title":"J. Mol. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1080\/14656566.2019.1663826","article-title":"Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"20","author":"Cozzolino","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/17512433.2017.1371011","article-title":"Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease","volume":"10","author":"Galassi","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2215\/CJN.04040411","article-title":"Vitamin D therapy in chronic kidney disease and end stage renal disease","volume":"7","author":"Melamed","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Palmer, S.C., McGregor, D.O., Craig, J.C., Elder, G., Macaskill, P., and Strippoli, G.F. (2009). Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst. Rev., CD008175.","DOI":"10.1002\/14651858.CD005633.pub2"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.kint.2016.09.024","article-title":"Vascular calcification in chronic kidney disease: Different bricks in the wall?","volume":"91","author":"Vervloet","year":"2017","journal-title":"Kidney Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"898125","DOI":"10.5402\/2013\/898125","article-title":"The pleiotropic effect of vitamin d","volume":"2013","author":"Lai","year":"2013","journal-title":"ISRN Nephrol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2215\/CJN.06910714","article-title":"Nutritional vitamin D supplementation in dialysis: A randomized trial","volume":"10","author":"Bhan","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/gfw080","article-title":"Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease","volume":"31","author":"Agarwal","year":"2016","journal-title":"Nephrol. Dial Transpl."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clnu.2017.04.020","article-title":"Serum 24,25-dihydroxyvitamin D3 response to native vitamin D2 and D3 Supplementation in patients with chronic kidney disease on hemodialysis","volume":"37","author":"Kaufmann","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2215\/CJN.06510909","article-title":"Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac dimension parameters","volume":"5","author":"Matias","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Villa-Bellosta, R., Mahillo-Fernandez, I., Ortiz, A., and Gonzalez-Parra, E. (2019). Questioning the Safety of Calcidiol in Hemodialysis Patients. Nutrients, 11.","DOI":"10.3390\/nu11050959"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Palmer, S.C., McGregor, D.O., Craig, J.C., Elder, G., Macaskill, P., and Strippoli, G.F. (2009). Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane Database Syst. Rev., CD005633.","DOI":"10.1002\/14651858.CD005633.pub2"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ckj\/sfw072","article-title":"FGF23 in kidney transplant: The strange case of Doctor Jekyll and Mister Hyde","volume":"9","author":"Cianciolo","year":"2016","journal-title":"Clin. Kidney J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.ajkd.2012.07.022","article-title":"CKD-mineral and bone disorder management in kidney transplant recipients","volume":"61","author":"Alshayeb","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000446863","article-title":"Vitamin D in Kidney Transplant Recipients: Mechanisms and Therapy","volume":"43","author":"Cianciolo","year":"2016","journal-title":"Am. J. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cca.2019.11.010","article-title":"Nutritional vitamin D in CKD: Should we measure? Should we treat?","volume":"501","author":"Capelli","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1046\/j.1523-1755.1998.00142.x","article-title":"Persistent secondary hyperparathyroidism after renal transplantation","volume":"54","author":"Messa","year":"1998","journal-title":"Kidney Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/13102818.2014.995415","article-title":"Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients","volume":"29","author":"Filipov","year":"2015","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"ref_75","first-page":"628","article-title":"Serum vitamin D levels in kidney transplant recipients: The importance of an immunosuppression regimen and sun exposure","volume":"15","author":"Eyal","year":"2013","journal-title":"ISR Med. Assoc. J."},{"key":"ref_76","first-page":"w13672","article-title":"Preserved circannual rhythm of vitamin D in kidney transplant patients","volume":"142","author":"Burkhalter","year":"2012","journal-title":"Swiss. Med. Wkly"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1046\/j.1523-1755.2003.00938.x","article-title":"The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling","volume":"63","author":"Rojas","year":"2003","journal-title":"Kidney Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12020-017-1369-3","article-title":"Raising awareness on the therapeutic role of cholecalciferol in CKD: A multidisciplinary-based opinion","volume":"59","author":"Giannini","year":"2018","journal-title":"Endocrine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.TP.0000149322.70295.A5","article-title":"A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids","volume":"79","author":"Wissing","year":"2005","journal-title":"Transplantation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ki.2008.549","article-title":"Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients","volume":"75","author":"Courbebaisse","year":"2009","journal-title":"Kidney Int."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1523-1755.2004.00432.x","article-title":"Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation","volume":"65","author":"Torres","year":"2004","journal-title":"Kidney Int."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/01.ASN.0000016082.70875.36","article-title":"Treatment with vitamin D and calcium reduces bone loss after renal transplantation: A randomized study","volume":"13","author":"Hoitsma","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.2013111185","article-title":"Paricalcitol for secondary hyperparathyroidism in renal transplantation","volume":"26","author":"Trillini","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/tri.12973","article-title":"Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study","volume":"30","author":"Pihlstrom","year":"2017","journal-title":"Transpl. Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1080\/08860220802406369","article-title":"The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: A prospective study","volume":"30","author":"Sahin","year":"2008","journal-title":"Ren Fail"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40620-015-0237-6","article-title":"Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients","volume":"29","author":"Barros","year":"2016","journal-title":"J. Nephrol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5414\/CN109735","article-title":"Vitamin D in kidney transplant recipients","volume":"93","author":"Battaglia","year":"2020","journal-title":"Clin. Nephrol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1159\/000355747","article-title":"New insights on the role of vitamin D in the progression of renal damage","volume":"37","author":"Lucisano","year":"2013","journal-title":"Kidney Blood Press Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archinte.168.11.1174","article-title":"25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study","volume":"168","author":"Giovannucci","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjcard.2010.05.027","article-title":"Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population","volume":"106","author":"Anderson","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCOUTCOMES.112.967604","article-title":"Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies","volume":"5","author":"Wang","year":"2012","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jchf.2014.11.013","article-title":"Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study","volume":"3","author":"Lutsey","year":"2015","journal-title":"JACC Heart Fail."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"51","DOI":"10.17219\/acem\/34690","article-title":"Low-Level Vitamin D Is Associated with Atrial Fibrillation in Patients with Chronic Heart Failure","volume":"25","author":"Belen","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"g2035","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/aje\/kwp227","article-title":"Vitamin D status and the risk of cardiovascular disease death","volume":"170","author":"Kilkkinen","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2011.03.020","article-title":"Vitamin D status and mortality risk in CKD: A meta-analysis of prospective studies","volume":"58","author":"Pilz","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-med-051214-025146","article-title":"Vitamin D and Cardiovascular Disease","volume":"67","author":"Wang","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease","volume":"28","author":"Foley","year":"1996","journal-title":"Am. J. Kidney Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/heartjnl-2016-310794","article-title":"Heart failure in patients with kidney disease","volume":"103","author":"Tuegel","year":"2017","journal-title":"Heart"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.kint.2016.12.008","article-title":"Impact of fluid status and inflammation and their interaction on survival: A study in an international hemodialysis patient cohort","volume":"91","author":"Dekker","year":"2017","journal-title":"Kidney Int."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","article-title":"1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter","volume":"282","author":"Yuan","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/en.2007-0805","article-title":"Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility","volume":"149","author":"Tishkoff","year":"2008","journal-title":"Endocrinology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jsbmb.2006.12.098","article-title":"Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse","volume":"103","author":"Simpson","year":"2007","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1172\/JCI113010","article-title":"Vitamin D3 and cardiovascular function in rats","volume":"79","author":"Weishaar","year":"1987","journal-title":"J. Clin. Investig."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MNH.0b013e32834de4ee","article-title":"Vitamin D: Roles in renal and cardiovascular protection","volume":"21","author":"Li","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0008-6363(99)00145-5","article-title":"The renin-angiotensin system and experimental heart failure","volume":"43","author":"Wollert","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/ajh\/hpt177","article-title":"Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats","volume":"27","author":"Freundlich","year":"2014","journal-title":"Am. J. Hypertens"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/s41598-017-02068-6","article-title":"FGF23\/FGFR4-mediated left ventricular hypertrophy is reversible","volume":"7","author":"Grabner","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fendo.2018.00189","article-title":"FGF23 Actions on Target Tissues-With and Without Klotho","volume":"9","author":"Richter","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000468952","article-title":"Fibroblast Growth Factor 23: Mineral Metabolism and Beyond","volume":"190","author":"Grabner","year":"2017","journal-title":"Contrib. Nephrol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1570161115666170310092202","article-title":"Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?","volume":"16","author":"Cianciolo","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","article-title":"Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy","volume":"94","author":"Wilkins","year":"2004","journal-title":"Circ. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","article-title":"Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease","volume":"31","author":"Flasbart","year":"2016","journal-title":"Nephrol. Dial Transpl."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/HYPERTENSIONAHA.108.119602","article-title":"Expression of the vitamin d receptor is increased in the hypertrophic heart","volume":"52","author":"Chen","year":"2008","journal-title":"Hypertension"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.111.032680","article-title":"Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy","volume":"124","author":"Chen","year":"2011","journal-title":"Circulation"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00223-012-9619-0","article-title":"Molecular mechanisms of vitamin D action","volume":"92","author":"Haussler","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0092-8674(02)00699-2","article-title":"NFAT signaling: Choreographing the social lives of cells","volume":"109","author":"Crabtree","year":"2002","journal-title":"Cell"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/ndt\/gfw454","article-title":"Vitamin D treatment attenuates cardiac FGF23\/FGFR4 signaling and hypertrophy in uremic rats","volume":"32","author":"Grabner","year":"2017","journal-title":"Nephrol. Dial Transpl."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4049\/jimmunol.160.1.209","article-title":"Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects","volume":"160","author":"Takeuchi","year":"1998","journal-title":"J. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajh\/hpy154","article-title":"Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies","volume":"32","author":"Czaya","year":"2019","journal-title":"Am. J. Hypertens"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsbmb.2016.03.028","article-title":"Cardiac effect of vitamin D receptor modulators in uremic rats","volume":"163","author":"Mizobuchi","year":"2016","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"F309","DOI":"10.1152\/ajprenal.00129.2014","article-title":"Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5\/6 nephrectomized rats","volume":"308","author":"Chen","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism","volume":"79","author":"Pereira","year":"2011","journal-title":"Kidney Int."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: The PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Banerjee, D., Chitalia, N., Ster, I.C., Appelbaum, E., Thadhani, R., Kaski, J.C., and Goldsmith, D. (2019). Impact of Vitamin D on Cardiac structure and function in CKD patients with hypovitaminosis D, a randomised controlled trial and meta-analysis. Eur Heart J. Cardiovasc. Pharmacother.","DOI":"10.1093\/ehjcvp\/pvz080"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/5\/1453\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:52:29Z","timestamp":1760161949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/5\/1453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,25]]},"references-count":133,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["nu13051453"],"URL":"https:\/\/doi.org\/10.3390\/nu13051453","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,25]]}}}